Primary and secondary prevention of stroke has changed considerably during
the last ten years Numerous trials have studied the use and efficacy of var
ious treatments that were previously used and defended on theoretical or an
ecdotal grounds. This article discusses cerebrovascular disease in subsets
and reviews treatments based on evidence in each case.